N-Ethylmaleimide (NEM)

N-Ethylmaleimide (NEM) is an inhibitor of Cysteine Proteases used in studies of Protein Degradation / Proteasome. In practice, this places the compound in experiments that measure ubiquitin-dependent turnover, proteostasis, and targeted protein degradation in inflammation and protein homeostasis models.

By inhibiting Cysteine Proteases, N-Ethylmaleimide (NEM) can be used to examine ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The protease annotation adds relevance to protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping in the same experimental setting. In inflammation and protein homeostasis models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Cysteine Proteases
• Pathway perturbation studies connected to Protein Degradation / Proteasome
• Concentration-response inhibition and target-dependence studies
• Protease-activity, cleavage, and substrate-processing assays

Overall, N-Ethylmaleimide (NEM) is appropriate when a defined chemical perturbant is needed to connect Cysteine Proteases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in inflammation and protein homeostasis models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.